ISSM update
Posted: Fri Dec 12, 2014 12:42 pm
Study: Testosterone Is Not Associated With Higher Cardiovascular Risk
A new study has found no association between testosterone replacement therapy and elevated cardiovascular risk in a group of older men.
The study results were presented at the American Heart Association Scientific Sessions conference in Chicago last month.
Researchers from the Intermountain Medical Center Heart Institute in Murray, Utah, USA analyzed the medical records of almost 5,700 men between the ages of 53 and 71. All members of the study sample had low testosterone at baseline.
The researchers looked at subsequent data covering three years or fewer, noting the men's later testosterone measurements and the number of major adverse cardiac events (MACEs), such as heart attack, stroke, and death.
At the three year mark, men who had had testosterone replacement therapy had lower rates of MACE and death when compared to those whose testosterone levels remained low during the study period.
More study is needed, however. The authors recommended a large, randomized clinical trial in younger men.
Their abstract was published in the November 25, 2014 issue of Circulation. Please click here for more information.
A new study has found no association between testosterone replacement therapy and elevated cardiovascular risk in a group of older men.
The study results were presented at the American Heart Association Scientific Sessions conference in Chicago last month.
Researchers from the Intermountain Medical Center Heart Institute in Murray, Utah, USA analyzed the medical records of almost 5,700 men between the ages of 53 and 71. All members of the study sample had low testosterone at baseline.
The researchers looked at subsequent data covering three years or fewer, noting the men's later testosterone measurements and the number of major adverse cardiac events (MACEs), such as heart attack, stroke, and death.
At the three year mark, men who had had testosterone replacement therapy had lower rates of MACE and death when compared to those whose testosterone levels remained low during the study period.
More study is needed, however. The authors recommended a large, randomized clinical trial in younger men.
Their abstract was published in the November 25, 2014 issue of Circulation. Please click here for more information.